Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

PNEUMOVAX™ 23, a 23-valent polysaccharide pneumococcal vaccine (PPV23), covers 65% to 91% of the isolates recovered from adult cases of invasive pneumococcal disease. Several studies have demonstrated that pneumococcal serotypes 31, 11A, 35F, 17F, 3, 16F, 19F, 15B, and 10A are associated with higher...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Ciprero, Karen L., Marchese, Rocio D., Richard, Patrick, Baudin, Martine, Sterling, Tina M., Manoff, Susan B., Radley, David, Stek, Jon E., Soubeyrand, Benoît, Grabenstein, John D., Samson, Sandrine I., Musey, Luwy K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2016
Témata:
Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994760/
https://ncbi.nlm.nih.gov/pubmed/27002793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1156270
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky